Modulation of the immune response to respiratory viruses by vitamin D

Nutrients

Volumn 7, Issue 6, 2015, Pages 4240-4270

  Greiller, Claire L ^a   Martineau, Adrian R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antiviral immunity; Respiratory viruses; Vitamin D

Indexed keywords

ALPHA INTERFERON; BETA DEFENSIN 2; BETA INTERFERON; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D; CXCL10 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CORONAVIRIDAE; ENTEROVIRUS; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN BOCAVIRUS; HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA VIRUS; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PARAMYXOVIRINAE; PROTEIN EXPRESSION; RESPIRATORY VIRUS; REVIEW; RHINOVIRUS; SYSTEMATIC REVIEW (TOPIC); UPREGULATION; VIRAL RESPIRATORY TRACT INFECTION; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; INFLUENZA A VIRUS; RESPIRATORY TRACT INFECTIONS; SECRETION (PROCESS); VIROLOGY; VIRUS DISEASES; VITAMIN D DEFICIENCY;

BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS;

CHEMOKINE CXCL10; DIETARY SUPPLEMENTS; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFLUENZA A VIRUS; INTERLEUKIN-6; INTERLEUKIN-8; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS; TUMOR NECROSIS FACTORS; VIRUS DISEASES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84930934273     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064240     Document Type: Review

References (198)

1. Atmar, R.; Piedra, P.; Patel, S.; Greenberg, S.; Couch, R.; Glezen, W. Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness. J. Clin. Microbiol.2012, 50, 506–508
2. Lu, Y.; Wang, S.; Zhang, L.; Xu, C.; Bian, C.; Wang, Z.; Ma, Y.; Wang, K.; Ma, L.; Meng, C.; et al. Epidemiology of Human Respiratory Viruses in Children with Acute Respiratory Tract Infections in Jinan, China. Clin. Dev. Immunol.2013, 2013, 8
3. Bicer, S.; Giray, T.; Çöl, D.; Erdağ, G.; Vitrinel, A.; Gürol, Y.; Çelik, G.; Kaspar, C.; Küçük, Ö. Virological and Clinical Characterizations of Respiratory Infections in Hospitalized Children. Ital. J. Pediatr.2013, 39, 22
4. Del Valle Mendoza, J.; Cornejo-Tapia, A.; Weilg, P.; Verne, E.; Nazario-Fuertes, R.; Ugarte, C.; del Valle, L.; Pumarola, T. Incidence of Respiratory Viruses in Peruvian Children with Acute Respiratory Infections. J. Med. Virol.2015, 87, 917–924
5. Hengst, M.; Häusler, M.; Honnef, D.; Scheithauer, S.; Ritter, K.; Kleines, M. Human Bocavirus-infection (HBoV): An important cause of severe viral obstructive bronchitis in children. Klin. Padiatr.2008, 220, 296–301
6. Osterholm, M.; Kelley, N.; Sommer, A.; Belongia, E. Efficacy and effectiveness of influenza vaccines: A systemic review and meta-analysis. Lancet Infect. Dis. 2012, 12, 36–44
7. Hsu, J.; Santesso, N.; Mustafa, R.; Brozek, J.; Chen, Y.; Hopkins, J.; Cheung, A.; Hovhannisyan, G.; Ivanova, L.; Flottorp, S.; et al. Antivirals for treatment of influenza: A systematic review and meta-analysis of observational studies. Ann. Intern. Med. 2012, 156, 512–524
8. Dobson, J.; Whitley, R.; Pocock, S.; Monto, A. Oseltamivir treatment for influenza in adults: A meta-analysis of randomised controlled trials. Lancet2015, 385, 1729–1737
9. Jefferson, T.; Jones, M.; Doshi, P.; Spencer, E.; Onakpoya, I.; Heneghan, C. Oseltamivir for influenza in adults and children: Systematic review of clinical study reports and summary of regulatory comments. BMJ 2014, 348, g2545
10. Legand, A.; Briand, S.; Shindo, N.; Brooks, W.; de Jong, M.; Farrar, J.; Aguilera, X.; Hayden, F. Addressing the public health burden of respiratory viruses: The Battle against Respiratory Viruses (BRaVe) Initiative. Future Virol. 2013, 8, 953–968
11. Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. Vitamin D: Modulator of the immune system. Curr. Opin. Pharmacol.2010, 10, 482–496
12. Hewison, M. Vitamin D and Innate and Adaptive Immunity. Vitam. Horm.2011, 86, 23–62
13. Jolliffe, D.; Griffiths, C.; Martineau, A. Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies. J. Steroid Biochem. Mol. Biol.2013, 136, 321–329
14. Aloia, J.; Talwar, S.; Pollack, S.; Yeh, J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch. Intern. Med.2005, 165, 1618–1623
15. Aloia, J.; Li-Ng, M. Re: Epidemic influenza and vitamin D. Epidemiol. Infect.2007, 135, 1095–1097
16. Laaksi, I.; Ruohola, J.; Mattila, V.; Auvinen, A.; Ylikomi, T.; Pihlajamäki, H. Vitamin D supplementation for the prevention of acute respiratory tract infection: A randomized, double-blinded trial among young Finnish men. J. Infect. Dis.2010, 202, 809–814
17. Urashima, M.; Segawa, T.; Okazaki, M.; Kurihara, M.; Wada, Y.; Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr.2010, 91, 1255–1260
18. Camargo, C.; Ganmaa, D.; Frazier, A.; Kirchberg, F.; Stuart, J.; Kleinman, K.; Sumberzul, N.; Rich-Edwards, J. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics2012, 130, e561–e567
19. Majak, P.; Olszowiec-Chlebna, M.; Smejda, K.; Stelmach, I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J. Allergy Clin. Immunol.2011, 127, 1294–1296
20. Li-Ng, M.; Aloia, J.; Pollack, S.; Cunha, B.; Mikhail, M.; Yeh, J.; Berbari, N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect.2009, 137, 1396–1404
21. Murdoch, D.; Slow, S.; Chambers, S.; Jennings, L.; Stewart, A.; Priest, P.; Florkowski, C.; Livesey, J.; Camargo, C.; Scragg, R. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: The VIDARIS randomized controlled trial. JAMA2012, 308, 1333–1339
22. Kumar, G.; Sachdev, H.; Chellani, H.; Rehman, A.; Singh, V.; Arora, H.; Filteau, S. Effect of weekly vitamin D supplements on mortality, morbidity, and growth of low birthweight term infants in India up to age 6 months: Randomised controlled trial. BMJ2011, 342, d2975
23. Manaseki-Holland, S.; Maroof, Z.; Bruce, J.; Mughal, M.; Masher, M.; Bhutta, Z.; Walraven, G.; Chandramohan, D. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: A randomised controlled superiority trial. Lancet2012, 379, 1419–1427
24. Jorde, R.; Witham, M.; Janssens, W.; Rolighed, L.; Borchhardt, K.; de Boer, I.; Grimnes, G.; Hutchinson, M. Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials. Scand. J. Infect. Dis.2012, 44, 126–132
25. Castro, M.; King, T.; Kunselman, S.; Cabana, M.; Denlinger, L.; Holguin, F.; Kazani, S.; Moore, W.; Moy, J.; Sorkness, C.; et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: The VIDI randomized clinical trial. JAMA 2014, 311, 2083–2091
26. Martineau, A.; MacLaughlin, B.; Hooper, R.; Barnes, N.; Jolliffe, D.; Greiller, C.; Kilpin, K.; McLaughlin, D.; Fletcher, G.; Mein, C.; et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015, 70, 451–457
27. Martineau, A.; James, W.; Hooper, R.; Barnes, N.; Jolliffe, D.; Greiller, C.; Islam, K.; McLaughlin, D.; Bhowmik, A.; Timms, P.; et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): A multicentre, double-blind, randomised controlled trial. Lancet Respir. Med.2015, 3, 120–130
28. Bergman, P.; Lindh, A.; Björkhem-Bergman, L.; Lindh, J. Vitamin D and respiratory tract infections: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE 2013, 8, e65835
29. Sha, Q.; Truong-Tran, A.; Plitt, J.; Beck, L.; Schleimer, R. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol.2004, 31, 358–364
30. Holt, P.; Strickland, D.; Wikström, M.; Jahnsen, F. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol.2008, 8, 142–152
31. Malmgaard, L.; Melchjorsen, J.; Bowie, A.; Mogensen, S.; Paludan, S. Viral activation of macrophages through TLR-dependent and -independent pathways. J. Immunol.2004, 173, 6890–6898
32. Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell2010, 140, 805–820
33. Kim, Y.; Brinkmann, M.; Paquet, M.; Ploegh, H. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature2008, 452, 234–238
34. Lund, J.; Alexopoulou, L.; Sato, A.; Karow, M.; Adams, N.; Gale, N.; Iwasaki, A.; Flavell, R. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA2004, 101, 5598–5603
35. Lund, J.; Sato, A.; Akira, S.; Medzhitov, R.; Iwasaki, A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med.2003, 198, 513–520
36. Alexopoulou, L.; Holt, A.; Medzhitov, R.; Flavell, R. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature2001, 413, 732–738
37. Kohlmeier, J.; Woodland, D. Immunity to respiratory viruses. Annu. Rev. Immunol.2009, 27, 61–82
38. Kurt-Jones, E.; Popova, L.; Kwinn, L.; Haynes, L.; Jones, L.; Tripp, R.; Walsh, E.; Freeman, M.; Golenbock, D.; Anderson, L.; et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol.2000, 1, 398–401
39. Shibata, T.; Motoi, Y.; Tanimura, N.; yamakawa, N.; Akashi-Takamura, S.; Miyake, K. Intracellular TLR4-MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes. Int. Immunol.2011, 23, 503–510
40. Dietrich, N.; Lienenklaus, S.; Weiss, S.; Gekara, N. Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS ONE2010, 5, e10250
41. Murawski, M.; Bowen, G.; Cerny, A.; Anderson, L.; Haynes, L.; Tripp, R.; Kurt-Jones, E.; Finberg, R. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol.2009, 83, 1492–1500
42. Pichlmair, A.; Schulz, O.; Tan, C.; Näslund, T.; Liljeström, P.; Weber, F.; Reis e Sousa, C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science2006, 314, 997–1001
43. Feng, Q.; Hato, S.; Langereis, M.; Zoll, J.; Virgen-Slane, R.; Peisley, A.; Hur, S.; Semler, B.; van Rij, R.; van Kuppeveld, F. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2012, 2, 1187–1196
44. Sabbah, A.; Chang, T.; Harnack, R.; Frohlich, V.; Tominaga, K.; Dube, P.; Xiang, Y.; Bose, S. Activation of innate immune antiviral responses by Nod2. Nat. Immunol.2009, 10, 1073–1080
45. Loo, Y.; Fornek, J.; Crochet, N.; Bajwa, G.; Perwitasari, O.; Martinez-Sobrido, L.; Akira, S.; Gill, M.; García-Sastre, A.; Katze, M.; et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008, 82, 335–345
46. Bowie, A.; Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol.2008, 8, 911–922
47. Newton, K.; Dixit, V. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 2012, 4, doi:10.1101/cshperspect.a006049
48. Godaly, G.; Bergsten, G.; Hang, L.; Fischer, H.; Frendéus, B.; Lundstedt, A.; Samuelsson, M.; Samuelsson, P.; Svanborg, C. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukoc. Biol.2001, 69, 899–906
49. Verbist, K.; Rose, D.; Cole, C.; Field, M.; Klonowski, K. IL-15 participates in the respiratory innate immune response to influenza virus infection. PLoS ONE2012, 7, e37539
50. Wareing, M.; Shea, A.; Inglis, C.; Dias, P.; Sarawar, S. CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol. 2007, 20, 369–378
51. Kugathasan, K.; Roediger, E.; Small, C.; McCormick, S.; Yang, P.; Xing, Z. CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen-primed T cells. BMC Immunol. 2008, 9, 1186–1197
52. Gordon, S.; Read, R. Macrophage defences against respiratory tract infections. Br. Med. Bull.2002, 61, 45–61
53. Gwyer Findlay, E.; Currie, S.; Davidson, D. Cationic host defence peptides: Potential as antiviral therapeutics. BioDrugs2013, 27, 479–493
54. Barlow, P.; Svoboda, P.; Mackellar, A.; Nash, A.; York, I.; Pohl, J.; Davidson, D.; Donis, R. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE2011, 6, e25333
55. Lai, Y.; Adhikarakunnathu, S.; Bhardwaj, K.; Ranjith-Kumar, C.; Wen, Y.; Jordan, J.; Wu, L.; Dragnea, B.; San Mateo, L.; Kao, C. LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS ONE2011, 6, e26632
56. Currie, S.; Findlay, E.; McHugh, B.; Mackellar, A.; Man, T.; Macmillan, D.; Wang, H.; Fitch, P.; Schwarze, J.; Davidson, D. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS ONE2013, 8, e73659
57. Reed, J.; Brewah, Y.; Delaney, T.; Welliver, T.; Burwell, T.; Benjamin, E.; Kuta, E.; Kozhich, A.; McKinney, L.; Suzich, J.; et al. Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis. J. Infect. Dis.2008, 198, 1783–1793
58. Schneider, C.; Nobs, S.; Heer, A.; Kurrer, M.; Klinke, G.; van Rooijen, N.; Vogel, J.; Kopf, M. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 2014, 10, e1004053
59. Braciale, T.; Sun, J.; Kim, T. Regulating the adaptive immune response to repiratory virus infection. Nat. Rev. Immunol.2012, 12, 295–305
60. Förster, R.; Davalos-Misslitz, A.; Rot, A. CCR7 and its ligand: Balancing immunity and tolerance. Nat. Rev. Immunol.2008, 8, 362–371
61. Trifilo, M.; Bergmann, C.; Kuziel, W.; Lane, T. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cells effector function and migration following viral infection. J. Virol.2003, 77, 4004–4014
62. Freeman, C.; Curtis, J.; Chensue, S. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am. J. Pathol.2007, 171, 767–776
63. Agostini, C.; Facco, M.; Siviero, M.; Carollo, D.; Galvan, S.; Cattelan, A.; Zambello, R.; Trentin, L.; Semenzato, G. CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am. J. Respir. Crit. Care Med. 2000, 161 (4 Pt 1), 1466–1473
64. Bromley, S.; Mempel, T.; Luster, A. Orchestrating the orchestrators: Chemokines in control of T cell traffic. Nat. Immunol.2008, 9, 970–980
65. Gerhard, W. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol.2001, 260, 171–190
66. Palladino, G.; Mozdzanowska, K.; Washko, G.; Gerhard, W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol. 1995, 69, 2075–2081
67. Jegaskanda, S.; Weinfurter, J.; Friedrich, T.; Kent, S. Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J. Virol.2013, 87, 5512–5522
68. Stoermer, K.; Morrison, T. Complement and viral pathogenesis. Virology2011, 411, 362–373
69. Zhang, J.; Li, G.; Liu, X.; Wang, Z.; Liu, W.; Ye, X. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. J. Gen. Virol.2009, 90, 2751–2758
70. Jones, G. Pharmacokinetics of vitamin D toxicity. Am. J. Clin. Nutr.2008, 88, 582–586
71. Heaney, R. Serum 25-hydroxyvitamin D is a reliable indicator of vitamin D status. Am. J. Clin. Nutr.2011, 94, 619–620
72. Vieth, R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr.1999, 69, 842–856
73. Norman, A.; Mizwicki, M.; Norman, D. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Mat. Rev. Drug Discov.2004, 3, 27–41
74. Huhtakangas, J.; Olivera, C.; Bishop, J.; Zanello, L.; Norman, A. The vitamin D receptor is present in caveolae-enriched plamsa membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol. Endocrinol.2004, 18, 2660–2671
75. Norman, A. Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology 2006, 147, 5542–5548
76. Campbell, F.; Xu, H.; El-Tanani, M.; Crowe, P.; Bingham, V. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissue-specific growth control. Biochem. Pharmacol.2010, 79, 1–9
77. Provvedini, D.; Tsoukas, C.; Deftos, L.; Manolagas, S. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science1983, 221, 1181–1183
78. Baeke, F.; Korf, H.; Overbergh, L.; Etten, E.V.; Verstuyf, A.; Gysemans, C.; Mathieu, C. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem. Mol. Biol.2010, 121, 221–227
79. Hewison, M.; Freeman, L.; Hughes, S.; Evans, K.; Bland, R.; Eliopoulos, A.; Kilby, M.; Moss, P.; Chakraverty, R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol.2003, 170, 5382–5390
80. Chen, S.; Sims, G.; Chen, X.; Gu, Y.; Chen, S.; Lipsky, P. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol.2007, 179, 1634–1647
81. Sigmundsdottir, H.; Pan, J.; Debes, G.; Alt, C.; Habtezion, A.; Soler, D.; Butcher, E. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat. Immunol.2007, 8, 285–293
82. Kriegel, M.; Manson, J.; Costenbader, K. Does vitamin D affect risk of developing autoimmune disease?: A systematic review. Semin. Arthritis Rheum.2011, 40, 512–531
83. Krishnan, A.; Trump, D.; Johnson, C.; Feldman, F. The role of vitamin D in cancer prevention and treatment. Endocrinol. Metab. Clin. North Am.2010, 39, 401–418
84. Wang, T.; Pencina, M.; Booth, S.; Jacques, P.; Ingelsson, E.; Lanier, K.; Benjamin, E.; D-Agostino, R.; Wolf, M.; Vasan, R. Vitamin D deficiency and risk of cardiovascular disease. Circulation2008, 117, 503–511
85. Ginde, A.; Mansbach, J.; Camargo, C. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med.2009, 169, 384–390
86. Adams, J.; Ren, S.; Arbelle, J.; Horiuchi, N.; Gray, R.; Clemens, T.; Shany, S. Regulated production and intracrine action of 1,25-dihydroxyvitamin D3 in the chick myelomonocytic cell line HD-11. Endocrinology1994, 134, 2567–2573
87. Reichel, H.; Koeffler, H.; Barbers, R.; Norman, A. Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J. Clin. Endocrinol. Metab.1987, 65, 1201–1209
88. Yuan, J.; Freemont, A.; Mawer, E.; Hayes, M. Regulation of 1 alpha, 25-dihydroxyvitamin D3 synthesis in macrophages from arthritic joints by phorbol ester, dibutyryl-cAMP and calcium ionophore (A23187). FEBS Lett1992, 311, 71–74
89. Ren, S.; Nguyen, L.; Wu, S.; Encinas, C.; Adams, J.; Hewison, M. Alternative splicing of vitamin D-24-hydroxylase: A novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J. Biol. Chem.2005, 280, 20604–20611
90. White, J. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun.2008, 76, 3837–3843
91. White, J. Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Arch. Biochem. Biophys.2012, 523, 58–63
92. Campbell, G.; Spector, S. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog. 2012, 8, e1003017
93. Evans, K.; Taylor, H.; Zehnder, D.; Kilby, M.; Bulmer, J.; Shah, F.; Adams, J.; Hewison, M. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: A novel form of humoral hypercalcemia of malignancy. Am. J. Pathol.2004, 165, 807–813
94. Stoffels, K.; Overbergh, L.; Giulietti, A.; Verlinden, L.; Bouillon, R.; Mathieu, C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J. Bone Miner. Res.2006, 21, 37–47
95. Fritsche, J.; Mondal, K.; Ehrnsperger, A.; Andreesen, R.; Kreutz, M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood2003, 102, 3314–3316
96. Enioutina, E.; Bareyan, D.; Daynes, R. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol. 2009, 182, 4296–4305
97. Enioutina, E.; Bareyan, D.; Daynes, R. TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine2008, 26, 601–613
98. Hansdottir, S.; Monick, M.; Hinde, S.; Lovan, N.; Look, D.; Hunninghake, G. Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense. J. Immunol.2008, 181, 7090–7099
99. Krutzik, S.; Hewison, M.; Liu, P.; Robles, J.; Stenger, S.; Adams, J.; Modlin, R. IL-15 links TLR2/1-induced macrophage differentiaition to the vitamin D-dependent antimicrobial pathway. J. Immunol.2008, 181, 7115–7120
100. Schrumpf, J.; van Sterkenburg, M.; Verhoosel, R.; Zuyderduyn, S.; Hiemstra, P. Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells. Infect. Immun.2012, 80, 4485–4494
101. Overbergh, L.; Stoffels, K.; Waer, M.; Verstuyf, A.; Bouillon, R.; Mathieu, C. Immune regulation of 25-hydroxyvitamin D-1 alpha-hydroxylase in human monocytic THP1 cells: Mechanisms of interferon-gamma-mediated induction. J. Clin. Endocrinol. Metab.2006, 91, 3566–3574
102. Edfeldt, K.; Liu, P.; Chun, R.; Fabri, M.; Schenk, M.; Wheelwright, M.; Keegan, C.; Krutzik, S.; Adams, J.; Hewison, M.; et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. USA 2010, 107, 22593–22598
103. Gyetko, M.; Hsu, C.; Wilkinson, C.; Patel, S.; Young, E. Monocyte 1 alpha-hydroxylase regulation: Induction by inflammatory cytokines and suppression by dexamethasone and uremia toxin. J. Leukoc. Biol.1993, 54, 17–22
104. Slatopolsky, E.; Dusso, A.; Brown, A. New analogs of vitamin D3. Kidney Int. Suppl. 1999, 73, S46–S51
105. Parton, R.; Simons, K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol.2007, 8, 185–194
106. Monkawa, T.; Yoshida, T.; Hayashi, M.; Saruta, T. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int. 2000, 58, 559–568
107. Sørensen, O.; Follin, P.; Johnsen, A.; Calafat, J.; Tjabringa, G.; Hiemstra, P.; VBorregaard, N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood2001, 97, 3951–3959
108. Agerberth, B.; Charo, J.; Werr, J.; Olsson, B.; Idali, F.; Lindbom, L.; Kiessling, R.; Jörnvall, H.; Wigzell, H.; Gudmundsson, G. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood2000, 96, 3086–3093
109. Bals, R.; Wang, X.; Zasloff, M.; Wilson, J. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA1998, 95, 9541–9546
110. Yang, D.; Chen, Q.; Schmidt, A.; Anderson, G.; Wang, J.; Wooters, J.; Oppenheim, J.J.; Chertov, O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med.2000, 192, 1069–1074
111. Tjabringa, G.; Ninaber, D.; Drijfhout, J.; Rabe, K.; Hiemstra, P. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int. Arch. Allergy Immunol.2006, 140, 103–112
112. Scott, M.; Davidson, D.; Gold, M.; Bowdish, D.; Hancock, R. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol.2002, 169, 3883–3891
113. Nagaoka, I.; Tamura, H.; Hirata, M. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol.2006, 176, 3044–3052
114. Davidson, D.; Currie, A.; Reid, G.; Bowdish, D.; MacDonald, K.; Ma, R.; Hancock, R.; Speert, D. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol.2004, 172, 1146–1156
115. Choi, K.; Chow, L.; Mookherjee, N. Cationic host defence peptides: Multifaceted role in immune modulation and inflammation. J. Innate Immun.2012, 4, 361–370
116. Wang, T.; Nestel, F.; Bourdeau, V.; Nagai, Y.; Wang, Q.; Liao, J.; Tavera-Mendoza, L.; Lin, R.; Hanrahan, J.; Mader, S.; et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol.2004, 173, 2909–2912
117. Gombart, A.; Borregaard, N.; Koeffler, H. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19, 1067–1077
118. Yim, S.; Dhawan, P.; Ragunath, C.; Christakos, S.; Diamond, G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros.2007, 6, 403–410
119. Weber, G.; Heilborn, J.; Chamorro Jimenez, C.; Hammarsjo, A.; Törmä, H.; Stahle, M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Investig. Dermatol.2005, 124, 1080–1082
120. Ganz, T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3, 710–720
121. Kota, S.; Sabbah, A.; Chang, T.; Harnack, R.; Xiang, Y.; Meng, X.; Bose, S. Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J. Biol. Chem.2008, 283, 22417–22429
122. Rigby, W.; Shen, L.; Ball, E.; Guyre, P.; Fanger, M. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): A morphologic, phenotypic, and functional analysis. Blood1984, 64, 1110–1115
123. Xu, H.; Soruri, A.; Gieseler, R.; Peters, J. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand. J. Immunol.1993, 38, 535–540
124. Wu, S.; Sun, J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov. Med.2011, 11, 325–335
125. Sly, L.; Lopez, M.; Nauseef, W.; Reiner, N. 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem.2001, 276, 35482–35493
126. Kim, H.; Kim, C.; Ryu, J.; Kim, M.; Park, C.; Lee, J.; Holtzman, M.; Yoon, J. Reactive oxygen species induce antiviral innate immune response through IFN-λ regulation in human nasal epithelial cells. Am. J. Respir. Cell Mol. Biol.2013, 49, 855–865
127. Strengert, M.; Jennings, R.; Davanture, S.; Hayes, P.; Gabriel, G.; Knaus, U. Mucosal reactive oxygen species are required for antiviral response: Role of Duox in influenza a virus infection. Antioxid. Redox Signal.2014, 20, 2695–2709
128. Soucy-Faulkner, A.; Mukawera, E.; Fink, K.; Martel, A.; Jouan, L.; Nzengue, Y.; Lamarre, D.; Vande Velde, C.; Grandvaux, N. Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog. 2010, 6, e1000930
129. Liu, G.; Zhai, Q.; Schaffner, D.; Bradburne, C.; Wu, A.; Hayford, A.; Popov, S.; Grene, E.; Bailey, C.; Alibek, K. IL-15 induces IFN-beta and iNOS gene expression, and antiviral activity of murine macrophage RAW 264.7 cells. Immunol. Lett.2004, 91, 171–178
130. Kleinert, H.; Schwarz, P.; Förstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem.2003, 384, 1343–1364
131. Lee, Y.; Lai, C.; Hsieh, S.; Shieh, C.; Huang, L.; Wu-Hsieh, B. Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model. Virus Res. 2013, 178, 411–422
132. Ríos-Ibarra, C.; Lozano-Sepulveda, S.; Muñoz-Espinosa, L.; Rincón-Sánchez, A.; Cordova-Fletes, C.; Rivas-Estilla, A. Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells. Arch. Virol.2014, 159, 3321–3328
133. Rockett, K.; Brookes, R.; Udalova, I.; Vidal, V.; Hill, A; Kwiatkowski, D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun.1998, 66, 5314–5321
134. Bao, B.; Ting, H.; Hsu, J.; Lee, Y. Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells. Int. J. Cancer2008, 122, 2699–2706
135. Chang, J.; Kuo, M.; Kuo, H.; Hwang, S.; Tsai, J.; Chen, H.; Lai, Y. 1-alpha,25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J. Lab. Clin. Med.2004, 143, 14–22
136. Gombart, A. Vitamin D: Oxidative Stress, Immunity, and Aging; CRC Press: Boca Raton, FL, USA, 2012
137. Richetta, C.; Faure, M. Autophagy in antiviral innate immunity. Cell. Microbiol.2013, 15, 368–376
138. Yuk, J.; Shin, D.; Lee, H.; Yang, C.; Jin, H.; Kim, K.; Lee, Z.; Lee, S.; Kim, J.; Jo, E. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe2009, 6, 231–243
139. Høyer-Hansen, M.; Nordbrandt, S.; Jäättelä, M. Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol. Med.2010, 16, 295–302
140. Sadeghi, K.; Wessner, B.; Laggner, U.; Ploder, M.; Tamandl, D.; Friedl, J.; Zügel, U.; Steinmeyer, A.; Pollak, A.; Roth, E.; et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol.2006, 36, 361–370
141. Manukyan, M.; Triantafilou, K.; Triantafilou, M.; Mackie, A.; Nilsen, N.; Espevik, T.; Wiesmüller, K.; Ulmer, A.; Heine, H. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol.2005, 35, 911–921
142. Oberg, F.; Botling, J.; Nilsson, K. Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J. Immunol. 1993, 150 (8 Pt 1), 3487–3495
143. Zhang, D.; Hetherington, C.; Gonzalez, D.; Chen, H.; Tenen, D. Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3. J. Immunol.1994, 153, 3276–3284
144. Schauber, J.; Dorschner, R.; Coda, A.; Büchau, A.; Liu, P.; Kiken, D.; Helfrich, Y.; Kang, S.; Elalieh, H.; Steinmeyer, A.; et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Investig.2007, 117, 803–811
145. Wang, T.; Dabbas, B.; Laperriere, D.; Bitton, A.; Soualhine, H.; Tavera-Mendoza, L.; Dionne, S.; Servant, M.; Bitton, A.; Seidman, E.; et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 2010, 285, 2227–2231
146. Penna, G.; Adorini, L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol.2000, 164, 2405–2411
147. Berer, A.; Stöckl, J.; Majdic, O.; Wagner, T.; Kollars, M.; Lechner, K.; Geissler, K.; Oehler, L. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 2000, 28, 575–583
148. Dam, T.; Møller, B.; Hindkjaer, J.; Kragballe, K. The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J. Investig. Dermatol. Symp. Proc.1996, 1, 72–77
149. Gauzzi, M.; Purificato, C.; Donato, K.; Jin, Y.; Wang, L.; Daniel, K.; Maghazachi, A.; Belardelli, F.; Adorini, L.; Gessani, S. Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: Impairment of functional activities and chemotaxis. J. Immunol.2005, 174, 270–276
150. Baeke, F.; Etten, E.; Overbergh, L.; Mathieu, C. Vitamin D3 and the immune system: Maintaining the balance in health and disease. Nutr. Res. Rev. 2007, 20, 106–118
151. D’Ambrosio, D.; Cippitelli, M.; Cocciolo, M.; Mazzeo, D.; di Lucia, P.; Lang, R.; Sinigaglia, F.; Panina-Bordignon, P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Investig.1998, 101, 252–262
152. Giovannini, L.; Panichi, V.; Migliori, M.; de Pietro, S.; Bertelli, A.; Fulgenzi, A.; Filippi, C.; Sarnico, I.; Taccola, D.; Palla, R.; et al. 1,25-dihydroxyvitamin D(3) dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium. Transpl. Proc.2001, 33, 2366–2368
153. Van Halteren, A.; van Etten, E.; de Jong, E.; Bouillon, R.; Roep, B.; Mathieu, C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes2002, 71, 2119–2125
154. Lemire, J.; Archer, D.; Beck, L.; Spiegelberg, H. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J. Nutr.1995, 125(Suppl. S6), 1704–1708
155. Xystrakis, E.; Kusumakar, S.; Boswell, S.; Peek, E.; Urry, Z.; Richards, D.; Adikibi, T.; Pridgeon, C.; Dallman, M.; Loke, T.; et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Investig.2006, 116, 146–155
156. Borish, L.; Aarons, A.; Rumbyrt, J.; Cvietusa, P.; Negri, J.; Wenzel, S. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol.1996, 97, 1288–1296
157. Tang, J.; Zhou, R.; Luger, D.; Zhu, W.; Silver, P.; Grajewski, R.; Su, S.; Chan, C.; Adorini, L.; Caspi, R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol.2009, 182, 4624–4632
158. Daniel, C.; Sartory, N.; Zahn, N.; Radeke, H.; Stein, J. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther.2008, 324, 23–33
159. Miossec, P.; Korn, T.; Kuchroo, V. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med.2009, 361, 888–898
160. Ma, C.; Chew, G.; Simpson, N.; Priyadarshi, A.; Wong, M.; Grimbacher, B.; Fulcher, D.; Tangye, S.; Cook, M. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med.2008, 205, 1551–1557
161. Barrat, F.; Cua, D.; Boonstra, A.; Richards, D.; Crain, C.; Savelkoul, H.; de Waal-Malefyt, R.; Coffman, R.; Hawrylowicz, C. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002, 195, 603–616
162. Jeffery, L.; Burke, F.; Mura, M.; Zheng, Y.; Qureshi, O.; Hewison, M.; Walker, L.; Lammas, D.; Raza, K.; Sansom, D. 1,25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol.2009, 183, 5458–5467
163. Rigby, W.; Denome, S.; Fanger, M. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Investig. 1987, 79, 1659–1664
164. Cippitelli, M.; Santoni, M. Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol.1998, 28, 3017–3030
165. Boonstra, A.; Barrat, F.; Crain, C.; Heath, V.; Savelkoul, H.; O’Garra, A. 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol.2001, 167, 4974–4980
166. Yang, M.; Rui, K.; Wang, S.; Lu, L. Regulatory B cells in autoimmune diseases. Cell Mol. Immunol.2013, 10, 122–132
167. Terrier, B.; Derian, N.; Schindre, Y.; Chaara, W.; Geri, G.; Zahr, N.; Mariampillai, K.; Rosenzwajg, M.; Carpentier, W.; Musset, L.; et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther. 2012, 14, R221
168. Cantorna, M.; Zhao, J.; Yang, L. Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc. Nutr. Soc.2012, 71, 62–66
169. Lysandropoulos, A.; Jaquiéry, E.; Jilek, S.; Pantaleo, G.; Schluep, M.; Du Pasquier, R. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J. Neuroimmunol.2011, 233, 240–244
170. Topilski, I.; Flaishon, L.; Naveh, Y.; Harmelin, A.; Levo, Y. and Shachar, I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur. J. Immunol.2004, 34, 1068–1076
171. Matheu, V.; Back, O.; Mondoc, E.; Issazadeh-Navikas, S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: Enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol.2003, 112, 585–592
172. Staeva-Vieira, T.; Freedman, L. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels in vitro polaization of primary murine CD4+ T cells. J. Immunol.2002, 168, 1181–1189
173. Kreindler, J.; Steele, C.; Nguyen, N.; Chan, Y.; Pilewski, J.; Alcorn, J.; Vyas, Y.; Aujla, S.; Finelli, P.; Blanchard, M.; et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J. Clin. Investig. 2010, 120, 3242–3254
174. Jeffery, L.; Wood, A.; Qureshi, O.; Hou, T.; Gardner, D.; Briggs, Z.; Kaur, S.; Raza, K.; Sansom, D. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J. Immunol.2012, 189, 5155–5164
175. Arruda, E.; Pitkäranta, A.; Witek, T.; Doyle, C.; Hayden, F. Frequency and natural history of rhinovirus infections in adults during autumn. J. Clin. Microbiol.1997, 35, 2864–2868
176. Kirkpatrick, G. The common cold. Prim. Care1996, 23, 657–675
177. Monto, A. Studies of the community and family: Acute respiratory illness and infection. Epidemiol. Rev. 1994, 16, 351–373
178. Brockman-Schneider, R.; Pickles, R.; Gern, J. Effects of vitamin D on airway epithelial cell morphology and rhinovirus replication. PLoS ONE2014, 9, e86755
179. Turner, T.; Kopp, B.; Paul, G.; Landgrave, L.; Hayes, D.; Thompson, R. Respiratory syncytial virus: Current and emerging treatment options. Clin. Outcomes Res.2014, 25, 217–225
180. Borchers, A.; Chang, C.; Gershwin, M.; Gershwin, L. Respiratory syncytial virus--a comprehensive review. Clin. Rev. Allergy Immunol.2013, 45, 331–379
181. Sigurs, N.; Gustafsson, P.; Bjarnason, R.; Lundberg, F.; Schmidt, S.; Sigurbergsson, F.; Kjellman, B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med.2005, 171, 137–141
182. Belderbos, M.; Houben, M.; Wilbrink, B.; Lentjes, E.; Bloemen, E.; Kimpen, J.; Rovers, M.; Bont, L. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics2011, 127, e1513–e1520
183. Drysdale, S.; Prendergast, M.; Alcazar, M.; Wilson, T.; Smith, M.; Zuckerman, M.; Broughton, S.; Rafferty, G.; Johnston, S.; Hodemaekers, H.; et al. Genetic predisposition of RSV infection-related respiratory morbidity in preterm infants. Eur. J. Pediatr.2014, 173, 905–912
184. McNally, J.; Sampson, M.; Matheson, L.; Hutton, B.; Little, J. Vitamin D receptor (VDR) polymorphisms and severe RSV bronchiolitis: A systematic review and meta-analysis. Pediatr. Pulmonol. 2014, 49, 790–799
185. Kresfelder, T.; Janssen, R.; Bont, L.; Pretorius, M.; Venter, M. Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. J. Med. Virol.2011, 83, 1834–1840
186. Randolph, A.; Yip, W.; Falkenstein-Hagander, K.; Weiss, S.; Janssen, R.; Keisling, S.; Bont, L. Vitamin D-binding protein haplotype is associated with hospitalization for RSV bronchiolitis. Clin. Exp. Allergy2014, 44, 231–237
187. Hansdottir, S.; Monick, M.; Lovan, N.; Powers, L.; Gerke, A.; Hunninghake, G. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J. Immunol.2010, 184, 965–974
188. Stoppelenburg, A.; von Hegedus, J.; Huis In’t Veld, R.; Bont, L.; Boes, M. Defective control of vitamin D receptor-mediated epithelial STAT1 signaling predisposes to severe respiratory syncytial virus bronchiolitis. J. Pathol. 2013, doi:10.1002/path.4267
189. Sacco, R.; Nonnecke, B.; Palmer, M.; Waters, W.; Lippolis, J.; Reinhardt, T. Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D3. PLoS ONE2012, 7, e33074
190. McGill, J.; Nonnecke, B.; Lippolis, J.; Reinhardt, T.; Sacco, R. Differential chemokine and cytokine production by neonatal bovine γδ T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection. Immunology2013, 139, 227–244
191. Khare, D.; Godbole, N.; Pawar, S.; Mohan, V.; Pandey, G.; Gupta, S.; Kiumar, D.; Dhole, T.; Godbole, M. Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. Eur. J. Nutr.2013, 52, 1405–1415
192. Bermejo-Martin, J.; Ortiz de Lejarazu, R.; Pumarola, T.; Rello, J.; Almansa, R.; Ramirez, P.; Martin-Loeches, I.; Varillas, D.; Gallegos, M.; Seron, C.; et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit. Care 2009, 13, R201
193. Doss, M.; White, M.; Tecle, T.; Gantz, D.; Crouch, E.; Jung, G.; Ruchala, P.; Waring, A.; Lehrer, R.; Hartshorn, K. Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J. Immunol.2009, 182, 7878–7887
194. Kriesel, J.; Spruance, J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine1999, 17, 1883–1888
195. Sundaram, M.; Talbot, H.; Zhu, Y.; Griffin, M.; Spencer, S.; Shay, D.; Coleman, L. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Vaccine2013, 31, 2057–2061
196. Principi, N.; Marchision, P.; Terranova, L.; Zampiero, A.; Baggi, E.; Daleno, C.; Tirelli, S.; Pelucchi, C.; Esposito, S. Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children. Hum. Vaccin Immunother.2013, 9, 969–974
197. Cooper, C.; Thorne, A. Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults. HIV Clin. Trials2011, 12, 275–276
198. Science, M.; Maguire, J.; Russell, M.; Smieja, M.; Walter, S.; Loeb, M. Serum 25-hydroxyvitamin d level and influenza vaccine immunogenicity in children and adolescents. PLoS ONE2014, 9, e83553.